James Priour's most recent trade in Zymeworks BC Inc was a trade of 510 Common Shares done at an average price of $29.5 . Disclosure was reported to the exchange on July 6, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zymeworks BC Inc | James Priour | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 29.49 per share. | 06 Jul 2021 | 510 | 2,513 (0%) | 0% | 29.5 | 15,040 | Common Shares |
| Zymeworks BC Inc | James Priour | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 2,266 | 2,953 (0%) | 0% | 0 | Common Shares | |
| Zymeworks BC Inc | James Priour | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 2,266 | 4,534 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | James Priour | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 27.93 per share. | 13 Apr 2021 | 950 | 2,003 (0%) | 0% | 27.9 | 26,533 | Common Shares |
| Zymeworks BC Inc | James Priour | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | James Priour | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 6,250 | 6,250 | - | - | Restricted Stock Unit |